To further identify whether the LINC00470/EGR2/SOX4 axis assumed an essential role in the effects of temozolomide treatment on glioblastoma, cell cycle distribution under different treatments was first examined by flow cytometry. The gene discussed is SOX4; the disease is glioblastoma.